Australia - angielski - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - noradrenaline (norepinephrine) acid tartrate monohydrate, quantity: 20 mg/ml (equivalent: noradrenaline (norepinephrine), qty 10 mg/ml) - injection, concentrated - excipient ingredients: water for injections; hydrochloric acid; sodium chloride - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion and drug reactions).,as an adjunct in the treatment of cardiac arrest. to restore and maintain an adequate blood pressure after an effective heartbeat and ventilation have been established by other means.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

medtas pty ltd - noradrenaline (norepinephrine) acid tartrate monohydrate, quantity: 7.548 mg (equivalent: noradrenaline (norepinephrine), qty 4 mg) - injection, concentrated - excipient ingredients: sodium chloride; water for injections; sodium metabisulfite - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion and drug reactions).,as an adjunct in the treatment of cardiac arrest. to restore and maintain an adequate blood pressure,after an effective heartbeat and ventilation have been established by other means.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

medtas pty ltd - noradrenaline (norepinephrine) acid tartrate monohydrate, quantity: 3.774 mg (equivalent: noradrenaline (norepinephrine), qty 2 mg) - injection, concentrated - excipient ingredients: water for injections; sodium chloride; sodium metabisulfite - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion and drug reactions).,as an adjunct in the treatment of cardiac arrest. to restore and maintain an adequate blood pressure after an effective heartbeat and ventilation have been established by other means.

Wielka Brytania - angielski - MHRA (Medicines & Healthcare Products Regulatory Agency)

0.25%) / adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules (advanz pharma - bupivacaine hydrochloride; adrenaline acid tartrate - solution for injection - 2.5mg/1ml ; 5microgram/1ml

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

biomed limited - noradrenaline acid tartrate monohydrate 0.12 mg/ml equivalent to 0.06mg/ml noradrenaline base;   - solution for infusion - 0.06 mg/ml - active: noradrenaline acid tartrate monohydrate 0.12 mg/ml equivalent to 0.06mg/ml noradrenaline base   excipient: glucose sodium metabisulfite water for injection - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion, and drug reactions).

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

biomed limited - noradrenaline acid tartrate monohydrate 0.159 g/l equivalent to 0.08 g/l noradrenaline base - solution for infusion - 0.08 mg/ml - active: noradrenaline acid tartrate monohydrate 0.159 g/l equivalent to 0.08 g/l noradrenaline base excipient: glucose sodium metabisulfite water for injection - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion, and drug reactions).

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

biomed limited - noradrenaline acid tartrate monohydrate 0.239 mg/ml equivalent to 0.12 mg/ml noradrenaline base;   - solution for infusion - 0.12 mg/ml - active: noradrenaline acid tartrate monohydrate 0.239 mg/ml equivalent to 0.12 mg/ml noradrenaline base   excipient: glucose sodium metabisulfite water for injection - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion, and drug reactions).

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

biomed limited - noradrenaline acid tartrate monohydrate 0.319 mg/ml equivalent to 0.16 mg/ml noradrenaline base;   - solution for infusion - 0.16 mg/ml - active: noradrenaline acid tartrate monohydrate 0.319 mg/ml equivalent to 0.16 mg/ml noradrenaline base   excipient: glucose sodium metabisulfite water for injection - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion, and drug reactions).

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

biomed limited - noradrenaline acid tartrate monohydrate 0.199 mg/ml equivalent to 0.1 mg/ml noradrenaline base;   - solution for infusion - 0.1 mg/ml - active: noradrenaline acid tartrate monohydrate 0.199 mg/ml equivalent to 0.1 mg/ml noradrenaline base   excipient: glucose sodium metabisulfite water for injection - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion, and drug reactions).

Australia - angielski - Department of Health (Therapeutic Goods Administration)

adrenaline -